Liver X receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: A key role for lysophosphatidylcholine acyltransferase 3

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 6, 2013, Pages 1171-1179

  Ishibashi, Minako ^a   Varin, Alexis ^a   Filomenko, Rodolphe ^a   Lopez, Tatiana ^a   Athias, Anne ^a   Gambert, Philippe ^a,b   Blache, Denis ^a   Thomas, Charles ^a   Gautier, Thomas ^a   Lagrost, Laurent ^a,b   Masson, David ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Arachidonic acid; Liver X receptor; Lysophosphatidylcholine acyltransferase; Macrophages; Prostaglandin E2

Indexed keywords

ACYLTRANSFERASE; ARACHIDONIC ACID; ICOSANOID; LIVER X RECEPTOR; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 3; PHOSPHATIDYLCHOLINE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; LIPID ANALYSIS; LIPID COMPOSITION; MACROPHAGE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ARACHIDONIC ACID; LIVER X RECEPTOR; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; MACROPHAGES; PROSTAGLANDIN E2;

1-ACYLGLYCEROPHOSPHOCHOLINE O-ACYLTRANSFERASE; ARACHIDONIC ACID; CELLS, CULTURED; DIMETHYL SULFOXIDE; DINOPROSTONE; EICOSANOIDS; HUMANS; INFLAMMATION; MACROPHAGES; MICROARRAY ANALYSIS; MONOCYTES; ORPHAN NUCLEAR RECEPTORS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; UP-REGULATION;

EID: 84879099171     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300812     Document Type: Article

References (35)

1. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-Activated nuclear receptors. Nature. 2008;454:470-477.
2. Zhu L, Bakovic M. Liver X receptor agonists inhibit the phospholipid regulatory gene CTP: phosphoethanolamine cytidylyltransferase-Pcyt2. Res Lett Biochem. 2008;2008:801849.
3. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med. 2003;9:213-219.
4. Huang W, Glass CK. Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol. 2010;30:1542-1549.
5. Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, Glass CK. Parallel SUMOylation-dependent pathways mediate geneand signal-specific transrepression by LXRs and PPARgamma. Mol Cell. 2007;25:57-70.
6. Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, Chinetti-Gbaguidi G. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ Res. 2007;101:40-49.
7. Töröcsik D, Baráth M, Benko S, Széles L, Dezso B, Póliska S, Hegyi Z, Homolya L, Szatmári I, Lányi A, Nagy L. Activation of liver X receptor sensitizes human dendritic cells to inflammatory stimuli. J Immunol. 2010;184:5456-5465.
8. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem. 1956;222:193-214.
9. Lands WE. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. J Biol Chem. 1958;231:883-888.
10. Shindou H, Hishikawa D, Harayama T, Yuki K, Shimizu T. Recent progress on acyl CoA: lysophospholipid acyltransferase research. J Lipid Res. 2009;50 Suppl:S46-S51.
11. Shindou H, Shimizu T. Acyl-CoA:lysophospholipid acyltransferases. J Biol Chem. 2009;284:1-5.
12. Hishikawa D, Shindou H, Kobayashi S, Nakanishi H, Taguchi R, Shimizu T. Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc Natl Acad Sci USA. 2008;105:2830-2835.
13. Zhao Y, Chen YQ, Bonacci TM, Bredt DS, Li S, Bensch WR, Moller DE, Kowala M, Konrad RJ, Cao G. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. J Biol Chem. 2008;283:8258-8265.
14. Chilton FH, Fonteh AN, Surette ME, Triggiani M, Winkler JD. Control of arachidonate levels within inflammatory cells. Biochim Biophys Acta. 1996;1299:1-15.
15. Jackson SK, Abate W, Tonks AJ. Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery. Pharmacol Ther. 2008;119:104-114.
16. Demeure O, Lecerf F, Duby C, Desert C, Ducheix S, Guillou H, Lagarrigue S. Regulation of LPCAT3 by LXR. Gene. 2011;470:7-11.
17. Kaluzny MA, Duncan LA, Merritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res. 1985;26:135-140.
18. Arnauld S, Fidaleo M, Clémencet MC, Chevillard G, Athias A, Gresti J, Wanders RJ, Latruffe N, Nicolas-Francès V, Mandard S. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643. Biochimie. 2009;91:1376-1386.
19. Yamazaki T, Hirose A, Sakamoto T, Okazaki M, Mitsumoto A, Kudo N, Kawashima Y. Peroxisome proliferators attenuate free arachidonic acid pool in the kidney through inducing lysophospholipid acyltransferases. J Pharmacol Sci. 2009;111:201-210.
20. Jain S, Zhang X, Khandelwal PJ, Saunders AJ, Cummings BS, Oelkers P. Characterization of human lysophospholipid acyltransferase 3. J Lipid Res. 2009;50:1563-1570.
21. Kazachkov M, Chen Q, Wang L, Zou J. Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids. 2008;43:895-902.
22. Yoshikawa T, Shimano H, Yahagi N, et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J Biol Chem. 2002;277:1705-1711.
23. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, Brown MS. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA. 2001;98:6027-6032.
24. Pérez-Chacón G, Astudillo AM, Ruipérez V, Balboa MA, Balsinde J. Signaling role for lysophosphatidylcholine acyltransferase 3 in receptorregulated arachidonic acid reacylation reactions in human monocytes. J Immunol. 2010;184:1071-1078.
25. Li Z, Ding T, Pan X, Li Y, Li R, Sanders PE, Kuo MS, Hussain MM, Cao G, Jiang XC. Lysophosphatidylcholine acyltransferase 3 knockdownmediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression. J Biol Chem. 2012;287:20122-20131.
26. Jackson SK, Abate W, Parton J, Jones S, Harwood JL. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. J Leukoc Biol. 2008;84:86-92.
27. Golej DL, Askari B, Kramer F, Barnhart S, Vivekanandan-Giri A, Pennathur S, Bornfeldt KE. Long-chain acyl-CoA synthetase 4 modulates prostaglandin E release from human arterial smooth muscle cells. J Lipid Res. 2011;52:782-793.
28. Kanter JE, Kramer F, Barnhart S, et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci USA. 2012;109:-e715-E724.
29. Arai H, Nagano Y, Narumiya S, Kita T. Decreased arachidonate metabolism in mouse peritoneal macrophages after foam cell transformation with oxidized low-density lipoproteins. J Biochem. 1992;112:482-487.
30. Leventhal AR, Leslie CC, Tabas I. Suppression of macrophage eicosanoid synthesis by atherogenic lipoproteins is profoundly affected by cholesterol-fatty acyl esterification and the Niemann-Pick C pathway of lipid trafficking. J Biol Chem. 2004;279:8084-8092.
31. Rigamonti E, Chinetti-Gbaguidi G, Staels B. Regulation of macrophage functions by PPAR-Alpha, PPAR-gamma, and LXRs in mice and men. Arterioscler Thromb Vasc Biol. 2008;28:1050-1059.
32. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr. 2001;131:1918-1927.
33. Kelley DS, Taylor PC, Nelson GJ, Mackey BE. Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men. Lipids. 1998;33:125-130.
34. Kobayashi T, Tahara Y, Matsumoto M, Iguchi M, Sano H, Murayama T, Arai H, Oida H, Yurugi-Kobayashi T, Yamashita JK, Katagiri H, Majima M, Yokode M, Kita T, Narumiya S. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest. 2004;114:784-794.
35. Wang M, Zukas AM, Hui Y, Ricciotti E, Puré E, FitzGerald GA. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci USA. 2006;103: 14507-14512.